1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Reduced expression of OXPHOS and DNA damage genes is linked to protection from microvascular complications in long-term type 1 diabetes : the PROLONG study
(
- Contribution to journal › Article
- 2020
-
Mark
Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms
(
- Contribution to journal › Article
-
Mark
Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes
(
- Contribution to journal › Article
- 2012
-
Mark
Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.
(
- Contribution to journal › Article
- 2011
-
Mark
Incidence of hyperthyroidism in Sweden
(
- Contribution to journal › Article
- 2008
-
Mark
Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005
(
- Contribution to journal › Article
- 2007
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
- 2006
-
Mark
Från primärvård till invasiv intervention. Den kärlsjuke patientens väg genom svensk sjukvård
(
- Contribution to journal › Article
- 2003
-
Mark
Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease: A prospective, randomized, double-blind, placebo-controlled study.
(
- Contribution to journal › Article